|
1
|
Cooper GM: The Cell: A Molecular Approach.
2nd edition. Sunderland (MA): Sinauer Associates. The Development
and Causes of Cancer. https://www.ncbi.nlm.nih.gov/books/NBK9963/. 2000.
|
|
2
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
American Cancer Society. Cancer Statistics
Center. http://cancerstatisticscenter.cancer.org. Accessed Dec
25, 2022.
|
|
4
|
World Health Organization (WHO): Editorial
Style Manual WHO, Geneva, p83-91, 1993.
|
|
5
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bertram JS: The molecular biology of
cancer. Mol Aspects Med. 21:167–223. 2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kontomanolis EN, Koutras A, Syllaios A,
Schizas D, Mastoraki A, Garmpis N, Diakosavvas M, Angelou K,
Tsatsaris G, Pagkalos A, et al: Role of oncogenes and
tumor-suppressor genes in carcinogenesis: A review. Anticancer Res.
40:6009–6015. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Welti J, Loges S, Dimmeler S and Carmeliet
P: Recent molecular discoveries in angiogenesis and antiangiogenic
therapies in cancer. J Clin Invest. 123:3190–3200. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kamali H, Golmohammadzadeh S, Zare H,
Nosrati R, Fereidouni M and Safarpour H: The recent advancements in
the early detection of cancer biomarkers by DNAzyme-assisted
aptasensors. J Nanobiotechnology. 20(438)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pan S and Chen R: Pathological implication
of protein post-translational modifications in cancer. Mol Aspects
Med. 86(101097)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hershko A and Ciechanover A: The ubiquitin
system. Annu Rev Biochem. 67:425–479. 1998.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Weissman AM: Themes and variations on
ubiquitylation. Nat Rev Mol Cell Biol. 2:169–178. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Komander D and Rape M: The ubiquitin code.
Annu Rev Biochem. 81:203–229. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Salas-Lloret D and González-Prieto R:
Insights in post-translational modifications: Ubiquitin and SUMO.
Int J Mol Sci. 23(3281)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liebl MP and Hoppe T: It's all about
talking: Two-way communication between proteasomal and lysosomal
degradation pathways via ubiquitin. Am J Physiol Cell Physiol.
311:C166–C178. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tu Y, Chen C, Pan J, Xu J, Zhou ZG and
Wang CY: The Ubiquitin Proteasome Pathway (UPP) in the regulation
of cell cycle control and DNA damage repair and its implication in
tumorigenesis. Int J Clin Exp Pathol. 5:726–738. 2012.PubMed/NCBI
|
|
20
|
Klionsky DJ and Schulman BA: Dynamic
regulation of macroautophagy by distinctive ubiquitin-like
proteins. Nat Struct Mol Biol. 21:336–345. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kerscher O, Felberbaum R and Hochstrasser
M: Modification of proteins by ubiquitin and ubiquitin-like
proteins. Annu Rev Cell Dev Biol. 22:159–180. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ciechanover A and Kwon YT: Degradation of
misfolded proteins in neurodegenerative diseases: Therapeutic
targets and strategies. Exp Mol Med. 47(e147)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Berndsen CE and Wolberger C: New insights
into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol.
21:301–307. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kravtsova-Ivantsiv Y and Ciechanover A:
Non-canonical ubiquitin-based signals for proteasomal degradation.
J Cell Sci. 125(Pt 3):539–548. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Buetow L and Huang DT: Structural insights
into the catalysis and regulation of E3 ubiquitin ligases. Nat Rev
Mol Cell Biol. 17:626–642. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Rotin D and Kumar S: Physiological
functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell
Biol. 10:398–409. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Metzger MB, Hristova VA and Weissman AM:
HECT and RING finger families of E3 ubiquitin ligases at a glance.
J Cell Sci. 125(Pt 3):531–537. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Joazeiro CA and Weissman AM: RING finger
proteins: Mediators of ubiquitin ligase activity. Cell.
102:549–552. 2000.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bernassola F, Karin M, Ciechanover A and
Melino G: The HECT family of E3 ubiquitin ligases: Multiple players
in cancer development. Cancer Cell. 14:10–21. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Dove KK, Stieglitz B, Duncan ED, Rittinger
K and Klevit RE: Molecular insights into RBR E3 ligase ubiquitin
transfer mechanisms. EMBO Rep. 17:1221–1235. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li W and Ye Y: Polyubiquitin chains:
Functions, structures, and mechanisms. Cell Mol Life Sci.
65:2397–2406. 2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dinudom A, Harvey KF, Komwatana P, Young
JA, Kumar S and Cook DI: Nedd4 mediates control of an epithelial
Na+ channel in salivary duct cells by cytosolic Na+. Proc Natl Acad
Sci USA. 95:7169–7173. 1998.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Goulet CC, Volk KA, Adams CM, Prince LS,
Stokes JB and Snyder PM: Inhibition of the epithelial Na+ channel
by interaction of Nedd4 with a PY motif deleted in Liddle's
syndrome. J Biol Chem. 273:30012–30017. 1998.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Harvey KF, Dinudom A, Komwatana P,
Jolliffe CN, Day ML, Parasivam G, Cook DI and Kumar S: All three WW
domains of murine Nedd4 are involved in the regulation of
epithelial sodium channels by intracellular Na+. J Biol Chem.
274:12525–12530. 1999.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Harvey KF, Dinudom A, Cook DI and Kumar S:
The Nedd4-like protein KIAA0439 is a potential regulator of the
epithelial sodium channel. J Biol Chem. 276:8597–8601.
2001.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kanelis V, Farrow NA, Kay LE, Rotin D and
Forman-Kay JD: NMR studies of tandem WW domains of Nedd4 in complex
with a PY motif-containing region of the epithelial sodium channel.
Biochem Cell Biol. 76:341–350. 1998.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ingham RJ, Gish G and Pawson T: The Nedd4
family of E3 ubiquitin ligases: Functional diversity within a
common modular architecture. Oncogene. 23:1972–1984.
2004.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Dodson EJ, Fishbain-Yoskovitz V,
Rotem-Bamberger S and Schueler-Furman O: Versatile communication
strategies among tandem WW domain repeats. Exp Biol Med (Maywood).
240:351–360. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Scheffner M and Kumar S: Mammalian HECT
ubiquitin-protein ligases: Biological and pathophysiological
aspects. Biochim Biophys Acta. 1843:61–74. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lee IH, Dinudom A, Sanchez-Perez A, Kumar
S and Cook DI: Akt mediates the effect of insulin on epithelial
sodium channels by inhibiting Nedd4-2. J Biol Chem.
282:29866–29873. 2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Goel P, Manning JA and Kumar S: NEDD4-2
(NEDD4L): The ubiquitin ligase for multiple membrane proteins.
Gene. 557:1–10. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lu X, Xu H, Xu J, Lu S, You S, Huang X,
Zhang N and Zhang L: The regulatory roles of the E3 ubiquitin
ligase NEDD4 family in DNA damage response. Front Physiol.
13(968927)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chaugule VK and Walden H: Specificity and
disease in the ubiquitin system. Biochem Soc Trans. 44:212–227.
2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Herrmann J, Soares SM, Lerman LO and
Lerman A: Potential role of the ubiquitin-proteasome system in
atherosclerosis: Aspects of a protein quality disease. J Am Coll
Cardiol. 51:2003–2010. 2008.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Potjewyd FM and Axtman AD: Exploration of
Aberrant E3 ligases implicated in Alzheimer's disease and
development of chemical tools to modulate their function. Front
Cell Neurosci. 15(768655)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Sun T, Liu Z and Yang Q: The role of
ubiquitination and deubiquitination in cancer metabolism. Mol
Cancer. 19(146)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Petroski MD: The ubiquitin system,
disease, and drug discovery. BMC Biochem. 9 (Suppl
1)(S7)2008.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Orlowski RZ and Kuhn DJ: Proteasome
inhibitors in cancer therapy: Lessons from the first decade. Clin
Cancer Res. 14:1649–1657. 2008.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Thandra KC and Barsouk A, Saginala K,
Aluru JS and Barsouk A: Epidemiology of lung cancer. Contemp Oncol
(Pozn). 25:45–52. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhang J, Cao R, Lian C, Cao T, Shi Y, Ma
J, Wang P and Xia J: Nitidine chloride suppresses NEDD4 expression
in lung cancer cells. Aging (Albany NY). 13:782–793.
2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Rajdev K, Siddiqui AH, Ibrahim U,
Patibandla P, Khan T and El-Sayegh D: An unusually aggressive large
cell carcinoma of the lung: Undiagnosed until autopsy. Cureus.
10(e2202)2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Amodio N, Scrima M, Palaia L, Salman AN,
Quintiero A, Franco R, Botti G, Pirozzi P, Rocco G, De Rosa N and
Viglietto G: Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a
PTEN negative regulator, in non-small-cell lung carcinomas. Am J
Pathol. 177:2622–2634. 2010.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zhang W, Zhang R, Zeng Y, Li Y, Chen Y,
Zhou J, Zhang Y, Wang A, Zhu J, Liu Z, et al: ALCAP2 inhibits lung
adenocarcinoma cell proliferation, migration and invasion via the
ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L.
Cell Death Dis. 12(755)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Song YH, Zhang CQ, Chen FF and Lin XY:
Upregulation of neural precursor cell expressed developmentally
downregulated 4-1 is associated with poor prognosis and
chemoresistance in lung adenocarcinoma. Chin Med J (Engl).
131:16–24. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
He H, Huang C, Chen Z, Huang H, Wang X and
Chen J: An outlined review for the role of Nedd4-1 and Nedd4-2 in
lung disorders. Biomed Pharmacother. 125(109983)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Georgescu MM: PTEN tumor suppressor
network in PI3K-Akt pathway control. Genes Cancer. 1:1170–1177.
2010.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wei C, Lin M, Jinjun B, Su F, Dan C, Yan
C, Jie Y, Jin Z, Zi-Chun H and Wu Y: Involvement of general control
nonderepressible kinase 2 in cancer cell apoptosis by
posttranslational mechanisms. Mol Biol Cell. 26:1044–1057.
2015.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Shao G, Wang R, Sun A, Wei J, Peng K, Dai
Q, Yang W and Lin Q: The E3 ubiquitin ligase NEDD4 mediates cell
migration signaling of EGFR in lung cancer cells. Mol Cancer.
17(24)2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Sakashita H, Inoue H, Akamine S, Ishida T,
Inase N, Shirao K, Mori M and Mimori K: Identification of the
NEDD4L gene as a prognostic marker by integrated microarray
analysis of copy number and gene expression profiling in non-small
cell lung cancer. Ann Surg Oncol. 20 (Suppl 3):S590–S598.
2013.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Li G, Song Z, Wu C, Li X, Zhao L, Tong B,
Guo Z, Sun M, Zhao J, Zhang H, et al: Downregulation of NEDD4L by
EGFR signaling promotes the development of lung adenocarcinoma. J
Transl Med. 20(47)2022.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Li R, Hu Z, Sun SY, Chen ZG, Owonikoko TK,
Sica GL, Ramalingam SS, Curran WJ, Khuri FR and Deng X: Niclosamide
overcomes acquired resistance to erlotinib through suppression of
STAT3 in non-small cell lung cancer. Mol Cancer Ther. 12:2200–2212.
2013.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Xie S, Xia L, Song Y, Liu H, Wang ZW and
Zhu X: Insights into the biological role of NEDD4L E3 ubiquitin
ligase in human cancers. Front Oncol. 11(774648)2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Lai XN, Li J, Tang LB, Chen WT, Zhang L
and Xiong LX: MiRNAs and LncRNAs: Dual roles in TGF-β
signaling-regulated metastasis in lung cancer. Int J Mol Sci.
21(1193)2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Qu MH, Han C, Srivastava AK, Cui T, Zou N,
Gao ZQ and Wang QE: miR-93 promotes TGF-β-induced
epithelial-to-mesenchymal transition through downregulation of
NEDD4L in lung cancer cells. Tumour Biol. 37:5645–5651.
2016.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Bai X, Jing L, Li Y, Li Y, Luo S, Wang S,
Zhou J, Liu Z and Diao A: TMEPAI inhibits TGF-β signaling by
promoting lysosome degradation of TGF-β receptor and contributes to
lung cancer development. Cell Signal. 26:2030–2039. 2014.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Sun A, Zhu J, Xia S, Li Y, Wu T, Shao G,
Yang W and Lin Q: MEKK5 interacts with and negatively regulates the
E3 ubiquitin ligase NEDD4 for mediating lung cancer cell migration.
Life (Basel). 11(1153)2021.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Saginala K and Barsouk A, Aluru JS, Rawla
P, Padala SA and Barsouk A: Epidemiology of bladder cancer. Med Sci
(Basel). 8(15)2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Sanli O, Dobruch J, Knowles MA, Burger M,
Alemozaffar M, Nielsen ME and Lotan Y: Bladder cancer. Nat Rev Dis
Primers. 3(17022)2017.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Wen W, Li J, Wang L, Xing Y, Li X, Ruan H,
Xi X, Xiong J and Kuang R: Inhibition of NEDD4 inhibits cell growth
and invasion and induces cell apoptosis in bladder cancer cells.
Cell Cycle. 16:1509–1514. 2017.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Wang X, Trotman LC, Koppie T, Alimonti A,
Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo
C, et al: NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.
Cell. 128:129–139. 2007.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Mao M, Yang L, Hu J, Liu B, Zhang X, Liu
Y, Wang P and Li H: Oncogenic E3 ubiquitin ligase NEDD4 binds to
KLF8 and regulates the microRNA-132/NRF2 axis in bladder cancer.
Exp Mol Med. 54:47–60. 2022.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Jing W, Wang G, Cui Z, Xiong G, Jiang X,
Li Y, Li W, Han B, Chen S and Shi B: FGFR3 Destabilizes PD-L1 via
NEDD4 to Control T-cell-mediated bladder cancer immune
surveillance. Cancer Res. 82:114–129. 2022.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Zhao H, Zhang J, Fu X, Mao D, Qi X, Liang
S, Meng G, Song Z, Yang R, Guo Z, et al: Integrated bioinformatics
analysis of the NEDD4 family reveals a prognostic value of
NEDD4L in clear-cell renal cell cancer. PeerJ.
9(e11880)2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Hu XY, Xu YM, Fu Q, Yu JJ and Huang J:
Nedd4L expression is downregulated in prostate cancer compared to
benign prostatic hyperplasia. Eur J Surg Oncol. 35:527–531.
2009.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Negoita S, Feuer EJ, Mariotto A, Cronin
KA, Petkov VI, Hussey SK, Benard V, Henley SJ, Anderson RN, Fedewa
S, et al: Annual report to the nation on the status of cancer, part
II: Recent changes in prostate cancer trends and disease
characteristics. Cancer. 124:2801–2814. 2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Butler SS, Muralidhar V, Zhao SG, Sanford
NN, Franco I, Fullerton ZH, Chavez J, D'Amico AV, Feng FY, Rebbeck
TR, et al: Prostate cancer incidence across stage, NCCN risk
groups, and age before and after USPSTF Grade D recommendations
against prostate-specific antigen screening in 2012. Cancer.
126:717–724. 2020.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016.PubMed/NCBI View Article : Google Scholar
|
|
79
|
McCrea E, Sissung TM, Price DK, Chau CH
and Figg WD: Androgen receptor variation affects prostate cancer
progression and drug resistance. Pharmacol Res. 114:152–162.
2016.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Zhang Y, Duan H, Zhao H, Qi L, Liu Y,
Zhang Z, Liu C, Chen L, Jin M, Guan Y, et al: Development and
evaluation of a PSMA-targeted nanosystem co-packaging docetaxel and
androgen receptor siRNA for castration-resistant prostate cancer
treatment. Pharmaceutics. 14(964)2022.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Zhao Y, Li J, Chen J, Ye M and Jin X:
Functional roles of E3 ubiquitin ligases in prostate cancer. J Mol
Med (Berl). 100:1125–1144. 2022.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Li H, Xu LL, Masuda K, Raymundo E, McLeod
DG, Dobi A and Srivastava S: A feedback loop between the androgen
receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer
cells. J Biol Chem. 283:28988–28995. 2008.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Zhang J, Xie JJ, Zhou SJ, Chen J, Hu Q, Pu
JX and Lu JL: Diosgenin inhibits the expression of NEDD4 in
prostate cancer cells. Am J Transl Res. 11:3461–3471.
2019.PubMed/NCBI
|
|
84
|
Kim SE, Paik HY, Yoon H, Lee JE, Kim N and
Sung MK: Sex- and gender-specific disparities in colorectal cancer
risk. World J Gastroenterol. 21:5167–5175. 2015.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Xi Y and Xu P: Global colorectal cancer
burden in 2020 and projections to 2040. Transl Oncol.
14(101174)2021.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Rattray NJW, Charkoftaki G, Rattray Z,
Hansen JE, Vasiliou V and Johnson CH: Environmental influences in
the etiology of colorectal cancer: The premise of metabolomics.
Curr Pharmacol Rep. 3:114–125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Parmar S and Easwaran H: Genetic and
epigenetic dependencies in colorectal cancer development.
Gastroenterol Rep (Oxf). 10(goac035)2022.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Hsieh MH, Kung PT, Kuo WY, Ke TW and Tsai
WC: Recurrence, death risk, and related factors in patients with
stage 0 colorectal cancer: A nationwide population-based study.
Medicine (Baltimore). 99(e21688)2020.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Mishra J, Drummond J, Quazi SH, Karanki
SS, Shaw JJ, Chen B and Kumar N: Prospective of colon cancer
treatments and scope for combinatorial approach to enhanced cancer
cell apoptosis. Crit Rev Oncol Hematol. 86:232–250. 2013.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Golshani G and Zhang Y: Advances in
immunotherapy for colorectal cancer: A review. Therap Adv
Gastroenterol. 13(1756284820917527)2020.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Eide PW, Cekaite L, Danielsen SA,
Eilertsen IA, Kjenseth A, Fykerud TA, Ågesen TH, Bruun J, Rivedal
E, Lothe RA and Leithe E: NEDD4 is overexpressed in colorectal
cancer and promotes colonic cell growth independently of the
PI3K/PTEN/AKT pathway. Cell Signal. 25:12–18. 2013.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Aikemu B, Shao Y, Yang G, Ma J, Zhang S,
Yang X, Hong H, Yesseyeva G, Huang L, Jia H, et al: NDRG1 regulates
Filopodia-induced Colorectal Cancer invasiveness via modulating
CDC42 activity. Int J Biol Sci. 17:1716–1730. 2021.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Zou X, Levy-Cohen G and Blank M: Molecular
functions of NEDD4 E3 ubiquitin ligases in cancer. Biochim Biophys
Acta. 1856:91–106. 2015.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Zhang S, Yu C, Yang X, Hong H, Lu J, Hu W,
Hao X, Li S, Aikemu B, Yang G, et al: N-myc downstream-regulated
gene 1 inhibits the proliferation of colorectal cancer through
emulative antagonizing NEDD4-mediated ubiquitylation of p21. J Exp
Clin Cancer Res. 38(490)2019.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Lu C, Thoeni C, Connor A, Kawabe H,
Gallinger S and Rotin D: Intestinal knockout of Nedd4 enhances
growth of Apcmin tumors. Oncogene. 35:5839–5849.
2016.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Tanksley JP, Chen X and Coffey RJ: NEDD4L
is downregulated in colorectal cancer and inhibits canonical WNT
signaling. PLoS One. 8(e81514)2013.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Liu J, Shaik S, Dai X, Wu Q, Zhou X, Wang
Z and Wei W: Targeting the ubiquitin pathway for cancer treatment.
Biochim Biophys Acta. 1855:50–60. 2015.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Wang K, Yu Y, Wang W, Jiang Y, Li Y, Jiang
X, Qiao Y, Chen L, Zhao X, Liu J, et al: Targeting the E3 ligase
NEDD4 as a novel therapeutic strategy for IGF1 signal
pathway-driven gastric cancer. Oncogene. 42:1072–1087.
2023.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Ahn Y, Hwang CY, Lee SR, Kwon KS and Lee
C: The tumour suppressor PTEN mediates a negative regulation of the
E3 ubiquitin-protein ligase Nedd4. Biochem J. 412:331–338.
2008.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Ao N, Chen Q and Liu G: The small
molecules targeting ubiquitin-proteasome system for cancer therapy.
Comb Chem High Throughput Screen. 20:403–413. 2017.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Wang X, Duan J, Fu W, Yin Z, Sheng J, Lei
Z and Wang H: Decreased expression of NEDD4L contributes to NSCLC
progression and metastasis. Biochem Biophys Res Commun.
513:398–404. 2019.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Yue M, Yun Z, Li S, Yan G and Kang Z:
NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer
progression under microRNA-340-5p suppression and ATF1
upregulation. RNA Biol. 18:1981–1995. 2021.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Kim SS, Yoo NJ, Jeong EG, Kim MS and Lee
SH: Expression of NEDD4-1, a PTEN regulator, in gastric and
colorectal carcinomas. APMIS. 116:779–784. 2008.PubMed/NCBI View Article : Google Scholar
|
